Oral IRAK4 inhibitor BAY-1834845 prevents acute respiratory distress syndrome-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Oral IRAK4 inhibitor BAY-1834845 prevents acute respiratory distress syndrome

Published:2022-09 Issue: Volume:153 Page:113459
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Li Qianqian,Li Rui,Yin Hanlin,Wang Suli,Liu Bei,Li Jun,Zhou Mi,Yan Qingran,Lu Liangjing

Funder

Shanghai Hospital Development Center

Health and Family Planning Commission of Sichuan Province

Shanghai Municipal Commission of Health and Family Planning

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference65 articles.

1. Acute respiratory distress syndrome in the trauma intensive care unit: morbid but not mortal;Salim;Arch. Surg.,2006

2. The acute respiratory distress syndrome;Matthay;J. Clin. Investig.,2012

3. Incidence and outcomes of acute lung injury;Rubenfeld;N. Engl. J. Med.,2005

4. Acute respiratory distress syndrome after convalescent plasma use: treatment of a patient with Ebola virus disease contracted in Madrid, Spain;Mora-Rillo;Lancet Respir. Med.,2015

5. Acute pancreatitis-associated lung injury: pathophysiological mechanisms and potential future therapies;Zhao;Scand. J. Gastroenterol.,2002

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modeling “Two-Hit” Severe Pneumonia in Mice: Pathological Characteristics and Mechanistic Studies;Inflammation;2024-08-30

2. Interleukin‐1 receptor‐associated kinase 4 (IRAK4) is a critical regulator of inflammatory signalling through toll‐like receptors 4 and 7/8 in murine and human lungs;British Journal of Pharmacology;2024-08-13

3. Inhibiting the IRAK4/NF-κB/NLRP3 signaling pathway can reduce pyroptosis in hippocampal neurons and seizure episodes in epilepsy;Experimental Neurology;2024-07

4. Fragment-Based Anti-inflammatory Agent Design and Target Identification: Discovery of AF-45 as an IRAK4 Inhibitor to Treat Ulcerative Colitis and Acute Lung Injury;Journal of Medicinal Chemistry;2024-06-24

5. Discovery of LC-MI-3: A Potent and Orally Bioavailable Degrader of Interleukin-1 Receptor-Associated Kinase 4 for the Treatment of Inflammatory Diseases;Journal of Medicinal Chemistry;2024-05-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3